Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetes

被引：0
|
作者：
Elza Muscelli
Brenno Astiarraga
Elisabetta Barsotti
Andrea Mari
Freimut Schliess
Leszek Nosek
Tim Heise
Uli C. Broedl
Hans-Juergen Woerle
Ele Ferrannini
机构：
[1] University of Pisa,Department of Clinical and Experimental Medicine
[2] C.N.R. Institute of Neuroscience,undefined
[3] Profil,undefined
[4] Boehringer Ingelheim Pharma GmbH & Co. KG,undefined
[5] CNR Institute of Clinical Physiology,undefined
来源：
Diabetologia | 2016年 / 59卷
关键词：
Empagliflozin; Endogenous glucose production; Glycosuria; Metformin; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：700 / 708
页数：8
相关论文
共 50 条
  • [1] Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetes
    Muscelli, Elza
    Astiarraga, Brenno
    Barsotti, Elisabetta
    Mari, Andrea
    Schliess, Freimut
    Nosek, Leszek
    Heise, Tim
    Broedl, Uli C.
    Woerle, Hans-Juergen
    Ferrannini, Ele
    DIABETOLOGIA, 2016, 59 (04) : 700 - 708
  • [2] Beneficial metabolic effects of empagliflozin alone and empagliflozin on top of metformin treatment in type 1 diabetes patients
    Lunder, M.
    Janic, M.
    Sabovic, M.
    Janez, A.
    DIABETOLOGIA, 2019, 62 : S345 - S345
  • [3] Initial combination of metformin, sitagliptin, and empagliflozin in drug-naive patients with type 2 diabetes: Safety and metabolic effects
    Lim, Soo
    Sohn, Minji
    Shin, Yujin
    Ferrannini, Ele
    DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 757 - 762
  • [4] Efficacy and tolerability of initial combination therapy with nateglinide and metformin in treatment-naive patients with type 2 diabetes
    Horton, ES
    Foley, JE
    Shen, SG
    Baron, MA
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (06) : 883 - 889
  • [5] Management of type 2 diabetes in treatment-naive elderly patients
    Pratley, Richard E.
    Rosenstock, Julio
    Pi-Sunyer, F. Xavier
    Banerji, Mary Ann
    Schweizer, Anja
    Couturier, Andre
    Dejager, Sylvie
    DIABETES CARE, 2007, 30 (12) : 3017 - 3022
  • [6] Sitagliptin and Metformin Decrease Plasma Glucose by Complementary Mechanisms in Treatment-Naive Patients with Type 2 Diabetes Mellitus
    Migoya, Elizabeth
    Morrow, Linda
    Gutierrez, Maria
    Miller, Jutta
    Luo, Wen-Lin
    O'Neill, Edward
    Stoch, Aubrey
    Wagner, John A.
    DIABETES, 2011, 60 : A268 - A269
  • [7] Nateglinide, alone or in combination with metformin, is effective and well tolerated in treatment-naive elderly patients with type 2 diabetes
    Schwarz, S. L.
    Gerich, J. E.
    Marcellari, A.
    Jean-Louis, L.
    Purkayastha, D.
    Baron, M. A.
    DIABETES OBESITY & METABOLISM, 2008, 10 (08): : 652 - 660
  • [8] Effect of saxagliptin monotherapy in treatment-naive patients with type 2 diabetes
    Rosenstock, J.
    Aguilar-Salinas, C.
    Klein, E.
    Nepal, S.
    List, J.
    Chen, R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (10) : 2401 - 2411
  • [9] Metformin Reduces Blood Glucose in Treatment-Naive Type 2 Diabetes by Altering the Gut Microbiome
    He, Daqiang
    Han, Hui
    Fu, Xiaodan
    Liu, Anbing
    Zhan, Yuhong
    Qiu, Haiyan
    Md, Lizhen Ma
    Zhang, Xianfeng
    Wang, Xianjun
    CANADIAN JOURNAL OF DIABETES, 2022, 46 (02) : 150 - 156
  • [10] The safety of empagliflozin plus metformin for the treatment of type 2 diabetes
    Scheen, Andre J.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (08) : 837 - 848
12345